Toxin News and Research

RSS

Scientist develops way to detect BoNT in biological samples

Many know Botox as a trendy way to get rid of wrinkles, but the popular drug — made from botulinum neurotoxin (BoNT) — can do more than just fill lines.

23 Sep 2016

Research findings may help better understand genetic origins of Familial Mediterranean Fever

A team of scientists led by Stony Brook University researchers have discovered a new mechanism for a bacterial toxin to inhibit inflammation.

19 Sep 2016

TSRI researchers find potential new weapon to combat C. difficile infections

Scientists at The Scripps Research Institute have discovered a potential new weapon against Clostridium difficile, a bacterium that causes hundreds of thousands of severe intestinal infections in the U.S. every year and is frequently fatal.

16 Sep 2016

Research findings of protein may form foundation for new approach to antibiotics

Researchers have made the first-ever detailed, atomic-level images of a peroxiredoxin, which has revealed a peculiar characteristic of this protein and might form the foundation for a new approach to antibiotics.

1 Sep 2016

New research may explain why people with blood group O get more severely ill from cholera

People with blood type O often get more severely ill from cholera than people of other blood types. New research from Washington University School of Medicine in St. Louis may explain why.

29 Aug 2016

Bacteria in smokeless tobacco products linked to opportunistic infections

Several species of bacteria found in smokeless tobacco products have been associated with opportunistic infections, according to a paper published August 26 in Applied and Environmental Microbiology, a journal of the American Society for Microbiology.

26 Aug 2016

Researchers explore molecular mechanisms through which lead exposure may affect neural stem cells

Researchers have identified a potential molecular mechanism through which lead, a pervasive environmental toxin, may harm neural stem cells and neurodevelopment in children.

26 Aug 2016

ESCMID releases new guidelines on best practices to detect C. difficile infections

The European Society of Clinical Microbiology and Infectious Diseases has just released new guidelines on best practice methods to diagnose Clostridium difficile infection (CDI).

26 Aug 2016

Botulinum toxins may cause remote effects by moving between neurons

The botulinum toxins are among the deadliest substances on Earth, and two specific toxins — including the popular drug Botox — have multiple uses for treating many neuromuscular conditions, including frown lines, disabling muscle spasms and migraine headaches.

5 Aug 2016

Study finds link between eczema and S. aureus bacteria

A new study published in the British Journal of Dermatology has shown that, on average, 70% of eczema patients are colonised with Staphylococcus aureus bacteria (S. aureus, including MRSA) on their skin lesions.

26 Jul 2016

Penn researchers develop plant-based oral vaccine booster

Jonas Salk created a vaccine against polio that has been used since 1955; Albert Sabin created another version that has been on the market since 1961. Together, these two vaccines have nearly eliminated polio from the face of the earth.

20 Jul 2016

Japanese researchers suggest link between stimulus response and consciousness

Japanese researchers centered at Nagoya University reveal a role for orexin neurons of the hypothalamus when mice respond to painful stimuli, and suggest a link between stimulus response and consciousness.

18 Jul 2016

UTSA researcher elucidates innovative strategies to track disease-causing pathogens

In a new study published in Frontiers in Microbiology, Mark Eppinger, assistant professor in the Department of Biology at The University of Texas at San Antonio describes innovative strategies to track disease-causing pathogens like E. coli. Eppinger hopes his research will aid in halting and preventing large-scale outbreaks.

11 Jul 2016

Researchers uncover sensing mechanism of food poisoning bacteria found in shellfish

UT Southwestern Medical Center researchers have uncovered a mechanism that a type of pathogenic bacteria found in shellfish use to sense when they are in the human gut, where they release toxins that cause food poisoning.

5 Jul 2016

Scientists explain how engineered anthrax toxin proteins could help eliminate cancerous tumors

Scientists from the National Institute of Allergy and Infectious Diseases, the National Institute of Dental and Craniofacial Research, and the National Heart, Lung and Blood Institute all parts of the National Institutes of Health, describe how combining engineered anthrax toxin proteins and existing chemotherapy drugs could potentially yield a therapy to reduce or eliminate cancerous tumors.

28 Jun 2016

Anthrax capsule vaccine offers protection from deadly anthrax infection in monkeys

Vaccination with the anthrax capsule--a naturally occurring component of the bacterium that causes the disease--completely protected monkeys from lethal anthrax infection, according to a study published online this week in the journal VACCINE.

27 Jun 2016

Study reveals distribution of toxic arsenic in cell nuclei of plants

Toxic arsenic initially accumulates in the nuclei of plants' cells. This has been revealed by an X-ray examination of the aquatic plant rigid hornwort (Ceratophyllum demersum) using DESY's X-ray source PETRA III.

25 Jun 2016

Paper-based testing device can identify occurrence of cyanobacteria toxins in swimming water

VTT Technical Research Centre of Finland and the University of Turku have developed an easy-to-use and affordable blue-green algae (cyanobacteria) test. The testing device enables ordinary consumers to check that the water at their beach is free of cyanobacteria toxins.

17 Jun 2016

New vaccine found safe, effective against Toxic Shock Syndrome

Toxic Shock Syndrome (TSS) is a severe circulatory and organ failure caused by bacterial toxins, usually triggered by bacteria from the Staphylococcus group. Researchers from MedUni Vienna's Department of Clinical Pharmacology, in collaboration with the company Biomedizinische Forschungsgesellschaft mbH in Vienna, have now developed the world's first safe and effective vaccine against this disease and successfully tested it in a Phase I trial.

13 Jun 2016

Metabolite of oral DMF drug for multiple sclerosis appears to slow onset of Parkinson's disease

The metabolite of a drug that is helping patients battle multiple sclerosis appears to significantly slow the onset of Parkinson's disease, researchers say.

9 Jun 2016

Toxin News and Research

Scientist develops way to detect BoNT in biological samples

Research findings may help better understand genetic origins of Familial Mediterranean Fever

TSRI researchers find potential new weapon to combat C. difficile infections

Research findings of protein may form foundation for new approach to antibiotics

New research may explain why people with blood group O get more severely ill from cholera

Bacteria in smokeless tobacco products linked to opportunistic infections

Researchers explore molecular mechanisms through which lead exposure may affect neural stem cells

ESCMID releases new guidelines on best practices to detect C. difficile infections

Botulinum toxins may cause remote effects by moving between neurons

Study finds link between eczema and S. aureus bacteria

Penn researchers develop plant-based oral vaccine booster

Japanese researchers suggest link between stimulus response and consciousness

UTSA researcher elucidates innovative strategies to track disease-causing pathogens

Researchers uncover sensing mechanism of food poisoning bacteria found in shellfish

Scientists explain how engineered anthrax toxin proteins could help eliminate cancerous tumors

Anthrax capsule vaccine offers protection from deadly anthrax infection in monkeys

Study reveals distribution of toxic arsenic in cell nuclei of plants

Paper-based testing device can identify occurrence of cyanobacteria toxins in swimming water

New vaccine found safe, effective against Toxic Shock Syndrome

Metabolite of oral DMF drug for multiple sclerosis appears to slow onset of Parkinson's disease

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News